Related Experiment Video
Updated: Mar 21, 2026
Generation of Natural Killer Cells from Human Expanded Potential Stem Cells
Published on: January 13, 2023
In Vitro Generation of Human NK Cells Expressing Chimeric Antigen Receptor Through Differentiation of Gene-Modified
Emily Lowe1, Laurel C Truscott2,3, Satiro N De Oliveira4,5
1Department of Microbiology, Immunology & Molecular Genetics, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
Abstract:
NK cells represent a very promising source for adoptive cellular approaches for cancer immunotherapy, and extensive research has been conducted, including clinical trials. Gene modification of NK cells can direct their specificity and enhance their function, but the efficiency of gene transfer techniques is very limited. Here we describe two protocols designed to generate mature human NK cells from gene-modified hematopoietic stem cells. These protocols use chimeric antigen receptor as the transgene, but could potentially be modified for the expression any particular transgene in human NK cells.
Insights
Generating mature, gene-modified human NK cells for cancer immunotherapy is challenging. New protocols using modified stem cells offer a promising approach to enhance NK cell function and specificity for adoptive cell therapy.
Area of Science:
- Immunology
- Cell Biology
- Biotechnology
Background:
- Natural Killer (NK) cells are crucial for cancer immunotherapy.
- Gene modification enhances NK cell specificity and function for adoptive cell therapy.
- Current gene transfer methods for NK cells have limited efficiency.
Purpose of the Study:
- To develop efficient protocols for generating mature, gene-modified human NK cells.
- To overcome limitations in gene transfer efficiency for NK cell engineering.
- To provide a platform for expressing transgenes, such as chimeric antigen receptors, in NK cells.
Main Methods:
- Utilizing gene-modified hematopoietic stem cells.
- Implementing two distinct protocols for NK cell generation.
- Focusing on generating mature human NK cells.
Main Results:
- Successful generation of mature human NK cells from gene-modified hematopoietic stem cells.
- Demonstrated feasibility of using chimeric antigen receptor as a transgene.
- Established protocols adaptable for various transgene expressions.
Conclusions:
- The developed protocols offer a viable strategy for producing gene-modified NK cells for cancer immunotherapy.
- This approach enhances the potential of adoptive NK cell therapy.
- The protocols can be adapted for diverse therapeutic transgenes.
